Guangdong Dtech Technology (01377) elected Wang Yifei as the employee representative director.
Ding Tai High-Tech (01377) announced that, as the term of the second board of directors is about to expire, the board proposes to nominate Ms. Wang Xin, Mr. Lin Xia, Mr. Wang Junfeng, and Mr. Wang Xuefeng as executive directors of the third board of directors, and Ms. Li Qiong, Dr. Luo Shuzhang, and Dr. Huang Hui as independent non-executive directors of the third board of directors.
Guangdong Dtech Technology (01377) announced that, as the term of the second board of directors is about to expire, the board proposes to nominate Ms. Wang Xin, Mr. Lin Xia, Mr. Wang Junfeng, and Mr. Wang Xuefeng as executive directors of the third board of directors, and Ms. Li Qiong, Dr. Luo Shuzhang, and Dr. Huang Hui as independent non-executive directors of the third board of directors.
According to the Company Law of the People's Republic of China and other relevant laws and regulations as well as the company's articles of association, the company will hold the 2nd Employee Representative Assembly of 2026 on August 19, 2026, to elect Ms. Wang Yifei as an employee representative director of the third board of directors. Ms. Wang Yifei will join the other directors elected by the companys extraordinary general meeting to form the third board of directors, with a term ending on the day the third board of directors completes its term.
Related Articles

US Stock Market Move | Gold stocks rose across the board, with Harmony Gold Mining Co. Ltd. Sponsored ADR (HMY.US) up by 7%.

BJ DIGITAL (06188) issues a profit warning, expecting a net loss attributable to shareholders of no more than 110 million yuan for the interim period.

KEYMED BIO-B (02162): It is recommended to issue shares in Renminbi and list on the Sci-Tech Innovation Board of the Shanghai Stock Exchange.
US Stock Market Move | Gold stocks rose across the board, with Harmony Gold Mining Co. Ltd. Sponsored ADR (HMY.US) up by 7%.

BJ DIGITAL (06188) issues a profit warning, expecting a net loss attributable to shareholders of no more than 110 million yuan for the interim period.

KEYMED BIO-B (02162): It is recommended to issue shares in Renminbi and list on the Sci-Tech Innovation Board of the Shanghai Stock Exchange.

RECOMMEND





